These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 5658858

  • 1. Biopharmaceutics and drug standards.
    Feldmann EG.
    Am J Hosp Pharm; 1968 Mar; 25(3):111-9. PubMed ID: 5658858
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Significance of biopharmaceutics for practical drug therapy].
    Dettli L.
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:57-63. PubMed ID: 5288609
    [No Abstract] [Full Text] [Related]

  • 4. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708
    [No Abstract] [Full Text] [Related]

  • 5. "Who shall establish drug standards"?
    Macek TJ.
    J Am Pharm Assoc; 1973 Mar; 13(3):122-3. PubMed ID: 4689929
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Drug standards laboratory enters second decade.
    Reese KM.
    J Am Pharm Assoc; 1972 Jan; 12(1):16-20. PubMed ID: 5007258
    [No Abstract] [Full Text] [Related]

  • 10. [Drug dosage form and action].
    Zathurecký L.
    Med Klin; 1974 Apr 19; 69(16):667-70. PubMed ID: 4837397
    [No Abstract] [Full Text] [Related]

  • 11. [A "new" mechanism behind the hypersensitive reactions to drug combinations. A report from a meeting].
    Naess K.
    Tidsskr Nor Laegeforen; 1973 Jan 30; 93(3):183-4. PubMed ID: 4693379
    [No Abstract] [Full Text] [Related]

  • 12. [Biochemical bases of drug action. Introduction].
    Büchi J.
    Pharm Acta Helv; 1968 Jun 30; 43(6):321-30. PubMed ID: 4880600
    [No Abstract] [Full Text] [Related]

  • 13. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC.
    J Nucl Med; 2004 Jun 30; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract] [Full Text] [Related]

  • 14. Quality drugs and the Saskatchewan formulary.
    Johnson GE.
    Can J Hosp Pharm; 1975 Jun 30; 28(3):84-6. PubMed ID: 10316621
    [No Abstract] [Full Text] [Related]

  • 15. New York State and drug lists: a history of confusion.
    Stetler CJ.
    Med Mark Media; 1978 Sep 30; 13(9):36, 38, 40 passim. PubMed ID: 10316687
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Formulation for optimal safety and effectiveness.
    Schlichting DA.
    Am J Pharm Sci Support Public Health; 1970 Sep 30; 142(1):16-22. PubMed ID: 5535904
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Introducing a new drug into clinical practice.
    Abrams WB.
    Anesthesiology; 1971 Aug 30; 35(2):176-92. PubMed ID: 4998617
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.